Get started
Voyager Therapeutics, Inc.
Long
Updated

Seismic shift incoming

275
Dark pools may be responsible for recent overselling w/2 near-term catalysts: 4/25 (presentation of its Phase 1b PD drug results at AAN Annual Meeting), 5/11 (earnings). Its PD (VY-AADC01) will shake the market if its phase 1b results can be replicated. Price should correct to $14-15 after a couple weeks. VYGR
Note
My position remains unchanged.
gothamist
VYGR

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
VYGR
gothamist

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.